Shuling Zhou

No ORCID on file · 3 papers in corpus
observational 2025
BMC cancer ·doi:10.1186/s12885-024-13389-x

BACKGROUND: To assess the utility of the TCGA molecular classification of endometrial cancer in a well-annotated, moderately sized, consecutive cohort of Chinese patients with ovarian clear cell carcinoma (OCCC). METHODS: We performed DNA …

other 2022
BMC cancer ·doi:10.1186/s12885-022-09204-0

BACKGROUND: This study aims to evaluate the role of the fibrinogen/albumin ratio (FAR) in predicting platinum resistance and survival outcomes of patients with ovarian clear cell carcinoma (OCCC). METHODS: Coagulation function and D-dimer,…

observational 2022
BMC cancer ·doi:10.1186/s12885-022-09588-z

BACKGROUND: The aim of the present study was to assess the prevalence of deficient mismatch repair (MMR) in Chinese ovarian clear cell carcinoma (CCC) patients and its association with clinicopathologic features. METHODS: Immunohistochemis…